Viruses and Gene Therapy The good news about viruses.

Post on 19-Dec-2015

218 views 3 download

Tags:

transcript

Viruses and Gene TherapyViruses and Gene Therapy

The good news about viruses

Quality of viral vectorQuality of viral vector

• Size of insert

• Integration or not/and where

• Ability to obtain in high titer

• Transduction efficiency

• Target cell specificity - pseudotyping

• Expression efficiency/control

• Possible pathogenicity or lack

• No immune response developed

Useful vectorsUseful vectors

• Retroviruses including HIV

• Adenovirus

• Adeno-associated virus (AAV)

• Herpes simplex virus

• Vaccinia virus

• DNA vectors

Virus Insert size

Transductionefficiency

Integration Targetcells

Problems

Retrovirus ~ 8 kb High Yes Dividing cells (pseudo- typed)

Insertional mutagenesis

Adeno-virus

~ 30 kb

High No Cells w/ receptor

Immunity

AAV ~ 4kb High Random or site sp.

Cells w/ receptor

Small insert size

HSV ~ 40 kb

Low No Neurons Latency/ immunity

Vaccinia ~ 25 kb

High No Cells w/ receptor

Immunity

RetrovirusesRetroviruses

• Require LTR and packaging signal– LTR modified not to

be a promotor– Cloned gene inserted

with strong promotor (pCMV) and may have IRES

– HIV vectors may have some accessory genes if LTR promotor is used (TAT)

Created using a packaging cell lineCreated using a packaging cell line

– Genes for gag/pol/env on separate plasmid to get packaging

– May have two or three plasmids for trans genes to reduce recombination

• Advantages:

– Stable integration

– Can design to target HIV infected cells with suicide gene

– Can add other promoters that respond only in specific cells

• Disadvantages:

– No replication and spread of vector

– Integration may be random

– Requires dividing cell to integrate and express

• What would happen to a retroviral vector with pCMV and HSV-TK injected into brain tumor and treatment with ganciclovir?

– No affect on neurons so can treat glioma

– TK activates ganciclovir and kills cells

• What would happen if used vector to add WT p53 gene to lung cancer tumor?

Adenovirus vectorsAdenovirus vectors

• Non-enveloped so no pseudotyping

• Requires elimination of early gene (E1 or E3) and other nonessential genes and becomes defective

• Packaging cell line has E gene integrated and expressed (less likely crossover)

• “Gutless” vectors have only the inverted terminal repeats (ITR) and a packaging signal and get all other gene products in trans in packaging cell

• Vector-infected cells are removed by immune system so transient response but that is reduced in gutless vector

• May not work at all if host starts with some Ad immunity

• Infects wide range of cells (common receptors)

Tumor destruction by adenovirusTumor destruction by adenovirus

• E1B region binds and inactivates p53 protein

• mutant adenovirus (dl1520) that cannot produce E1B won’t reproduce

• tumor cells lacking functional p53 can support replication of this virus

• C33A lacks p53

• U2OS has p53

• Circles = WT

• Squares = mutant

Which side has the Wt? The mutant?Which side has the Wt? The mutant?

Tumors in mice after treatment with Wt or Tumors in mice after treatment with Wt or mutantmutant

Adenovirus carries lots of DNAAdenovirus carries lots of DNA

• Put human hepatitis B genome into ad cloning vector (removed E1 and E3 genes)

• Hep genome also had GFP linked to pCMV as marker to recognize transduced cells

• Used to create HepB cell line in mouse cells that produces infectious viruses from nonintegrated DNA

• Infected mouse as well - small animal model

• Crossed species barrier

AAV - parvovirusAAV - parvovirus

• Requires adenovirus early genes to replicate - not related

• ssDNA with promoter and two genes - capsid and replication protein

• Terminal repeats allow for specific integration into genome if helper is not there

• Vector has TR and Promoter - no rep and capsid; insert size is small

• W/o rep integration is at random

• Correcting hemophilia in dogs - AAV vector with factor IX

• Tumor reduction - AAV vector with angiostatin

HSV vectors come in three varietiesHSV vectors come in three varieties

• Recombinant virus made replication deficient w/o IE gene

• Replication conditional replicate in certain cell lines

• Amplicon - bacterial plasmid-based

• Neurotropic but problems with immunity

• Large virus with many nonessential genes - can add 150KB

HSV ampliconsHSV amplicons

• Plasmid contains

– HSV ORI

– HSV packaging signal

– IE promoter and gene of interest

– Selection marker

• Virus made in cell that provides all other proteins in trans